Cargando…
Structure and dynamics of pteridine reductase 1: the key phenomena relevant to enzyme function and drug design
Pteridine reductase 1 (PTR1) is a folate and pterin pathway enzyme unique for pathogenic trypanosomatids. As a validated drug target, PTR1 has been the focus of recent research efforts aimed at finding more effective treatments against human parasitic diseases such as leishmaniasis or sleeping sickn...
Autores principales: | Panecka-Hofman, Joanna, Poehner, Ina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618315/ https://www.ncbi.nlm.nih.gov/pubmed/37608196 http://dx.doi.org/10.1007/s00249-023-01677-6 |
Ejemplares similares
-
Multitarget, Selective
Compound Design Yields Potent
Inhibitors of a Kinetoplastid Pteridine Reductase 1
por: Pöhner, Ina, et al.
Publicado: (2022) -
Application of a simple quantum chemical approach to ligand fragment scoring for Trypanosoma brucei pteridine reductase 1 inhibition
por: Jedwabny, Wiktoria, et al.
Publicado: (2017) -
Structure-Based Design and
Synthesis of Antiparasitic
Pyrrolopyrimidines Targeting Pteridine Reductase 1
por: Khalaf, Abedawn I., et al.
Publicado: (2014) -
Structure-Based Design of Pteridine Reductase Inhibitors Targeting African Sleeping Sickness and the Leishmaniases
por: Tulloch, Lindsay B., et al.
Publicado: (2009) -
Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate
por: Dawson, Alice, et al.
Publicado: (2006)